Pharmaceuticals in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Asia-Pacific pharmaceuticals market had total revenues of $424.4 billion in 2022, representing a compound annual growth rate (CAGR) of 9.1% between 2017 and 2022.
- 0
- The Asia-Pacific region acquired a 32.7% share of the global pharmaceuticals market in 2022. The growth in the pharmaceuticals market is mainly due to the growth in emerging markets such as China and India. Emerging markets bring new opportunities to pharmaceutical companies.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Asia-Pacific
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Asia-Pacific
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific pharmaceuticals market with five year forecasts by both value and volume
Reasons to Buy
- What was the size of the Asia-Pacific pharmaceuticals market by value in 2022?
- What will be the size of the Asia-Pacific pharmaceuticals market in 2027?
- What factors are affecting the strength of competition in the Asia-Pacific pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in Asia-Pacific's pharmaceuticals market?
Table of Contents
1 Executive Summary
2 Market Overview
3 Market Data
4 Market Segmentation
5 Market Outlook
6 Five Forces Analysis
7 Competitive Landscape
8 Company Profiles
9 Macroeconomic Indicators
10 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Yangtze River Pharmaceutical Group
- Shanghai Pharmaceuticals Holding Co Ltd
- Daiichi Sankyo Co Ltd
- Takeda Pharmaceutical Company Limited
